A booster dose of an inactivated enterovirus 71 vaccine in chinese young children: a randomized, double-blind, placebo-controlled clinical trial.
School of Public Health, Southeast University.
Jiangsu Provincial Center for Disease Control and Prevention, Nanjing College of Pharmacy, Third Military Medical University National Engineering Research Center for Immunological Products, Chongqing.
National Institute for Food and Drug Control.
Beijing Vigoo Biological, China.
Jiangsu Provincial Center for Disease Control and Prevention, Nanjing.
- Published Article
The Journal of Infectious Diseases
Oxford University Press
- Publication Date
Oct 01, 2014
A booster dose of EV71 vaccine 1 year after the priming EV71 immunization shows excellent immunogenicity and good safety profile. Clinical Trials Registration: NCT01734408.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 04/18/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/24625805